426 related articles for article (PubMed ID: 15958871)
1. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA
Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome: cardiovascular risk assessment and management.
Wong ND
Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
[TBL] [Abstract][Full Text] [Related]
3. [Treatment principles for the metabolic syndrome].
Boulogne A; Vantyghem MC
Presse Med; 2004 Jun; 33(10):673-81. PubMed ID: 15257242
[TBL] [Abstract][Full Text] [Related]
4. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
Houston MC; Basile J; Bestermann WH; Egan B; Lackland D; Hawkins RG; Moore MA; Reed J; Rogers P; Wise D; Ferrario CM
Am J Med Sci; 2005 Jun; 329(6):276-91. PubMed ID: 15958870
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for special populations: diabetes mellitus and the metabolic syndrome.
Sowers JR
Am J Hypertens; 2003 Nov; 16(11 Pt 2):41S-45S. PubMed ID: 14625160
[TBL] [Abstract][Full Text] [Related]
6. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
Goldberg RB; Mather K
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
[TBL] [Abstract][Full Text] [Related]
7. Management of hypertension in children and adolescents with the metabolic syndrome.
Puri M; Flynn JT
J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
[TBL] [Abstract][Full Text] [Related]
8. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
9. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
Rosenson RS
Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
[TBL] [Abstract][Full Text] [Related]
10. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
Venkatapuram S; Shannon RP
Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924
[TBL] [Abstract][Full Text] [Related]
11. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile J; Houston M; Ferrario CM
J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
[No Abstract] [Full Text] [Related]
12. The metabolic syndrome: diagnosis and treatment.
Zieve FJ
Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
[TBL] [Abstract][Full Text] [Related]
13. Management of metabolic syndrome and cardiovascular risk after liver transplantation.
Fatourou EM; Tsochatzis EA
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):731-741. PubMed ID: 31387736
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
Rehring TF; Stolcpart RS; Hollis HW;
J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
[TBL] [Abstract][Full Text] [Related]
15. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
Hoerger TJ; Ahmann AJ
J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
[TBL] [Abstract][Full Text] [Related]
16. Reducing CV risk in diabetes: An ADA update.
Skolnik N; Jaffa FM; Kalyani RR; Johnson E; Shubrook JH
J Fam Pract; 2017 May; 66(5):300-308. PubMed ID: 28459890
[TBL] [Abstract][Full Text] [Related]
17. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
[TBL] [Abstract][Full Text] [Related]
18. [Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk].
Kékes E
Orv Hetil; 2008 Sep; 149(39):1827-37. PubMed ID: 18805771
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: demographic features, etiology, and clinical management.
Wyne KL
Curr Atheroscler Rep; 2005 Sep; 7(5):381-8. PubMed ID: 16105482
[TBL] [Abstract][Full Text] [Related]
20. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome.
López-Jaramillo P; Barbosa E; Molina DI; Sanchez R; Diaz M; Camacho PA; Lanas F; Pasquel M; Accini JL; Ponte-Negretti CI; Alcocer L; Cobos L; Wyss F; Sebba-Barroso W; Coca A; Zanchetti A;
J Hypertens; 2019 Jun; 37(6):1126-1147. PubMed ID: 30882601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
